Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christoph Stephan

Showing results (101-110 of 146) with videos related to

Pageof 15
Sort By:
Clinical and Vaccine Immunology : CVI|April 18, 2014
Safety and immunogenicity of a vero cell culture-derived whole-virus H5N1 influenza vaccine in chronically ill and immunocompromised patientsMaikel V W van der Velden, Alexander Geisberger, Thomas Dvorak, et al.
Emerging Infectious Diseases|September 18, 2020
Drug Resistance Spread in 6 Metropolitan Regions, Germany, 2001-2018<sup>1</sup>Melanie Stecher, Antoine Chaillon, Christoph Stephan, et al.
The Journal of Infection|November 17, 2021
High overall mortality of Mycobacterium genavense infections and impact of antimycobacterial therapy: Systematic review and individual patient data meta-analysisNils Wetzstein, Johanna Kessel, Tobias M Bingold, et al.
Environmental Research|September 26, 2022
Aerosol measurement identifies SARS-CoV 2 PCR positive adults compared with healthy controlsDesireé Gutmann, Gerhard Scheuch, Timon Lehmkühler, et al.
The Lancet. HIV|February 28, 2024
Switching to dolutegravir plus rilpivirine versus maintaining current antiretroviral therapy regimen in virologically suppressed people with HIV-1 and the Lys103Asn (K103N) mutation: 48-week results from a randomised, open-label pilot clinical trialGraeme Moyle, Lambert Assoumou, Nathalie de Castro, et al.
JMIR Public Health and Surveillance|February 13, 2026
Clinical Epidemiology of Cancer in People Living With HIV in Germany: Retrospective, Observational, Multicenter Federated Claims Data AnalysisBastian Reiter, Stefanie Andreas, Linnea Schumann, et al.
Plos One|January 22, 2021
Colonization with multidrug-resistant organisms is associated with in increased mortality in liver transplant candidatesPhilip G Ferstl, Natalie Filmann, Eva-Maria Heilgenthal, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 26, 2020
Withholding Primary Pneumocystis Pneumonia Prophylaxis in Virologically Suppressed Patients With Human Immunodeficiency Virus: An Emulation of a Pragmatic Trial in COHEREAndrew Atkinson, Marcel Zwahlen, Diana Barger, et al.
AIDS Patient Care and Stds|February 11, 2021
Not Recommended, But Done: Breastfeeding with HIV in GermanyLila Haberl, Franz Audebert, Cornelia Feiterna-Sperling, et al.
HIV Medicine|October 7, 2025
Antiretroviral treatment in people living with HIV with late diagnosis initiating ART with DTG/3TC or BIC/TAF/FTC: A real-world cohort analysisGundolf Schuettfort, Jan Borch, Alfonso Cabello, et al.
Pageof 15

Showing results (101-110 of 146) with videos related to

Sort By:
Pageof 15
Clinical and Vaccine Immunology : CVI|April 18, 2014
Safety and immunogenicity of a vero cell culture-derived whole-virus H5N1 influenza vaccine in chronically ill and immunocompromised patientsMaikel V W van der Velden, Alexander Geisberger, Thomas Dvorak, et al.
Emerging Infectious Diseases|September 18, 2020
Drug Resistance Spread in 6 Metropolitan Regions, Germany, 2001-2018<sup>1</sup>Melanie Stecher, Antoine Chaillon, Christoph Stephan, et al.
The Journal of Infection|November 17, 2021
High overall mortality of Mycobacterium genavense infections and impact of antimycobacterial therapy: Systematic review and individual patient data meta-analysisNils Wetzstein, Johanna Kessel, Tobias M Bingold, et al.
Environmental Research|September 26, 2022
Aerosol measurement identifies SARS-CoV 2 PCR positive adults compared with healthy controlsDesireé Gutmann, Gerhard Scheuch, Timon Lehmkühler, et al.
The Lancet. HIV|February 28, 2024
Switching to dolutegravir plus rilpivirine versus maintaining current antiretroviral therapy regimen in virologically suppressed people with HIV-1 and the Lys103Asn (K103N) mutation: 48-week results from a randomised, open-label pilot clinical trialGraeme Moyle, Lambert Assoumou, Nathalie de Castro, et al.
JMIR Public Health and Surveillance|February 13, 2026
Clinical Epidemiology of Cancer in People Living With HIV in Germany: Retrospective, Observational, Multicenter Federated Claims Data AnalysisBastian Reiter, Stefanie Andreas, Linnea Schumann, et al.
Plos One|January 22, 2021
Colonization with multidrug-resistant organisms is associated with in increased mortality in liver transplant candidatesPhilip G Ferstl, Natalie Filmann, Eva-Maria Heilgenthal, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 26, 2020
Withholding Primary Pneumocystis Pneumonia Prophylaxis in Virologically Suppressed Patients With Human Immunodeficiency Virus: An Emulation of a Pragmatic Trial in COHEREAndrew Atkinson, Marcel Zwahlen, Diana Barger, et al.
AIDS Patient Care and Stds|February 11, 2021
Not Recommended, But Done: Breastfeeding with HIV in GermanyLila Haberl, Franz Audebert, Cornelia Feiterna-Sperling, et al.
HIV Medicine|October 7, 2025
Antiretroviral treatment in people living with HIV with late diagnosis initiating ART with DTG/3TC or BIC/TAF/FTC: A real-world cohort analysisGundolf Schuettfort, Jan Borch, Alfonso Cabello, et al.
Pageof 15